Abstract
MicroRNAs are small RNAs that are deregulated under disease conditions. This allows them to be used as biomarkers for disease diagnosis. Recently, such microRNAs are serving as non- invasive blood based biomarkers due to ease of detection, and high stability at room temperature in biofluids. In view of these advancements in biomarker research, efficient miRNA detection at the femtomolar level is important. MiRNA detection techniques to date include Northern blotting, real time PCR and microarray technology. While these are efficient techniques, they cannot detect very low miRNA levels, and have questionable specificity. This review describes nanotechnology, microfluidics and liquid phase miRNA detection techniques that are highly sensitive and specific. With some sophistication, some of these techniques can be used as point of care devices to rapidly detect low level miRNA in patient clinical samples to aid disease diagnosis and prognosis.
Keywords: Biomarker, isothermal amplification, liquid phase binding, microfluidics, modified in situ hybridization probes, microRNA detection, nanotechnology.
MicroRNA
Title:A Focus on Microfluidics and Nanotechnology Approaches for the Ultra Sensitive Detection of MicroRNA
Volume: 3 Issue: 1
Author(s): Swathi Lingam, Madhu Beta, Dhananjay Dendukuri and Subramanian Krishnakumar
Affiliation:
Keywords: Biomarker, isothermal amplification, liquid phase binding, microfluidics, modified in situ hybridization probes, microRNA detection, nanotechnology.
Abstract: MicroRNAs are small RNAs that are deregulated under disease conditions. This allows them to be used as biomarkers for disease diagnosis. Recently, such microRNAs are serving as non- invasive blood based biomarkers due to ease of detection, and high stability at room temperature in biofluids. In view of these advancements in biomarker research, efficient miRNA detection at the femtomolar level is important. MiRNA detection techniques to date include Northern blotting, real time PCR and microarray technology. While these are efficient techniques, they cannot detect very low miRNA levels, and have questionable specificity. This review describes nanotechnology, microfluidics and liquid phase miRNA detection techniques that are highly sensitive and specific. With some sophistication, some of these techniques can be used as point of care devices to rapidly detect low level miRNA in patient clinical samples to aid disease diagnosis and prognosis.
Export Options
About this article
Cite this article as:
Lingam Swathi, Beta Madhu, Dendukuri Dhananjay and Krishnakumar Subramanian, A Focus on Microfluidics and Nanotechnology Approaches for the Ultra Sensitive Detection of MicroRNA, MicroRNA 2014; 3 (1) . https://dx.doi.org/10.2174/2211536602666131210001511
DOI https://dx.doi.org/10.2174/2211536602666131210001511 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated with Varicose Veins
Current Drug Targets Phytoestrogens in Postmenopause: The State of the Art from a Chemical, Pharmacological and Regulatory Perspective
Current Medicinal Chemistry Therapeutic Use of Brentuximab Vedotin in CD30+ Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine Breast Cancer in the Personal Genomics Era
Current Genomics Anti-Cancer Potential of a Novel SERM Ormeloxifene
Current Medicinal Chemistry Irradiation Toxicity and Inflammatory Bowel Diseases (IBD): Review
Reviews on Recent Clinical Trials Carotenoids and Modulation of Cancer: Molecular Targets
Current Pharmacogenomics Variances in the Expression Profile of the EMT-Related Genes in Endometrial Cancer Lines <i>In Vitro</i> Study
Current Pharmaceutical Biotechnology Multi- and Inter-Disciplinary Science in Personalized Delivery of Stem Cells for Tissue Repair
Current Stem Cell Research & Therapy Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia
Current Psychiatry Reviews Sarcoidosis and Sarcoid Reactions in Endometrial Cancer Cases Masquerading Advanced Stage Malignancy
Current Women`s Health Reviews Elastic Liposomes for Topical and Transdermal Drug Delivery
Current Drug Delivery Adiponectin: A Key Player in Obesity Related Disorders
Current Pharmaceutical Design The Role of Diabetes in Molecular Pathogenesis of Cancer
Current Signal Transduction Therapy Targeting Ovarian Cancer-Initiating Cells
Anti-Cancer Agents in Medicinal Chemistry Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Review of Characteristics, Pharmacology, Determination and Pharmacokinetics of Rhaponticin
Mini-Reviews in Organic Chemistry Electrochemically Driven Supramolecular Interaction of Quinones and Ferrocifens: An Example of Redox Activation of Bioactive Compounds
Current Topics in Medicinal Chemistry Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)